B Acute Lymphoblastic Leukemia — Trials

B Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

345 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 151
Recruiting: 94
Ph III recruiting: 11
Growth YoY: +3.6%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 45.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 101–150 of 156 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04499573	Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL	active not recruiting	Phase 1 / Phase 2	50	Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER	1	Feb 22, 2023	clinicaltrials
NCT00849147	Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)	completed	Phase 2	55	Medical College of WisconsinOTHER	1	Jan 4, 2023